Abiomed investor relations material

Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It provides Impella 2.5 system, a percutaneous micro heart pump with integrated motor and sensors for use by interventional cardiologists to treat patients in cardiogenic shock; Impella CP system which enables physicians to treat patients needing circulatory support; Impella 5.0 system that provides left ventricular support; and Impella LD heart pump for use in high risk percutaneous coronary interventions.